ATE552005T1 - Pharmazeutische zusammensetzung hyaluronan als aktive komponente enthaltend - Google Patents
Pharmazeutische zusammensetzung hyaluronan als aktive komponente enthaltendInfo
- Publication number
- ATE552005T1 ATE552005T1 AT06020126T AT06020126T ATE552005T1 AT E552005 T1 ATE552005 T1 AT E552005T1 AT 06020126 T AT06020126 T AT 06020126T AT 06020126 T AT06020126 T AT 06020126T AT E552005 T1 ATE552005 T1 AT E552005T1
- Authority
- AT
- Austria
- Prior art keywords
- pharmaceutical composition
- composition containing
- active component
- containing hyaluronan
- hyaluronan
- Prior art date
Links
- KIUKXJAPPMFGSW-MNSSHETKSA-N hyaluronan Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)C1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H](C(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-MNSSHETKSA-N 0.000 title 1
- 229940099552 hyaluronan Drugs 0.000 title 1
- 229920002674 hyaluronan Polymers 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
- A61K31/728—Hyaluronic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Transplantation (AREA)
- Dermatology (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2005277918A JP2007084509A (ja) | 2005-09-26 | 2005-09-26 | 細胞賦活剤 |
| JP2005297991A JP2007106688A (ja) | 2005-10-12 | 2005-10-12 | サイトカイン関連遺伝子及びケモカイン関連遺伝子の発現抑制剤 |
| JP2005348017A JP2007153761A (ja) | 2005-12-01 | 2005-12-01 | シナプス伝達促進剤及びシナプス保護剤 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE552005T1 true ATE552005T1 (de) | 2012-04-15 |
Family
ID=37667620
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT06020126T ATE552005T1 (de) | 2005-09-26 | 2006-09-26 | Pharmazeutische zusammensetzung hyaluronan als aktive komponente enthaltend |
Country Status (7)
| Country | Link |
|---|---|
| EP (1) | EP1767211B1 (de) |
| AR (1) | AR056091A1 (de) |
| AT (1) | ATE552005T1 (de) |
| BR (1) | BRMU8603015U (de) |
| CA (1) | CA2560844C (de) |
| NO (1) | NO20064337L (de) |
| RU (1) | RU2342148C2 (de) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1994934A4 (de) | 2006-12-05 | 2010-03-10 | Glycoscience Lab Inc | Therapeutisches mittel gegen degenerative arthritis |
| JP5117110B2 (ja) * | 2007-05-28 | 2013-01-09 | 生化学工業株式会社 | Ｉ型アレルギー疾患治療剤 |
| EP2818172A4 (de) * | 2012-02-22 | 2016-02-17 | Hyaluronan Res Inst Inc | Tlr4-mittel, gewebehomöostatikum, hepatozytenwachstumsfaktorinduktor, gewebereparierendes mittel und sirtuininduktor mit hyaluronsäurefragmenten als wirkstoffe davon |
| IT201600079773A1 (it) * | 2016-07-29 | 2018-01-29 | Matteo Bevilacqua | Composizioni contenenti oligosaccaridi di acido ialuronico (HA4), condroitin solfato (CS2-4) ed eparan solfato (HS2-4), triterpeni pentaciclici e derivati per uso medico curativo e metodo per la preparazione di tali composizioni. |
| ES2974415T3 (es) * | 2021-05-07 | 2024-06-27 | Trb Chemedica Ag | Acido hialurónico para prevenir o tratar la disfunción neurológica de nervios o células nerviosas |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3419785B2 (ja) * | 1995-09-28 | 2003-06-23 | サングスタット メディカル コーポレイション | 免疫抑制剤としてのヒアルロン酸の使用 |
| JP4195107B2 (ja) * | 1996-02-16 | 2008-12-10 | 生化学工業株式会社 | ストレス蛋白質発現増強剤 |
| IT1309588B1 (it) * | 1999-03-05 | 2002-01-24 | Altergon Sa | Cerotto con spessore sottile contenente betametasone ed acidoialuronico per il trattamento di psoriasi, dermatite, dermatosi. |
| JP2003089647A (ja) * | 1999-03-10 | 2003-03-28 | Takada Seiyaku Kk | 関節性疾患治療剤 |
| CN100369925C (zh) * | 2000-07-07 | 2008-02-20 | 生化学工业株式会社 | 透明质酸低聚糖级分及含有该物质的药品 |
| US6537968B1 (en) * | 2000-07-24 | 2003-03-25 | Alphamed Pharmaceuticals Corp | Treatment of lupus erythematosus |
| DE60230388D1 (de) * | 2001-03-15 | 2009-01-29 | Seikagaku Kogyo Co Ltd | Mittel zur steurung der expression von il-12 |
| US7060691B2 (en) * | 2002-10-10 | 2006-06-13 | Giuseppe Petrigni | Pharmaceutical colloidal preparation useful in the treatment of respiratory diseases |
| US7511026B2 (en) * | 2003-03-25 | 2009-03-31 | Seikagaku Corporation | Therapeutic agent for nerve damage |
| HUP0303779A2 (en) * | 2003-11-20 | 2006-02-28 | Richter Gedeon Vegyeszet | Pharmaceutical compositions containing hyaluronan complex for the treatment of sclerosis multiplex |
| DE102004002001A1 (de) * | 2004-01-14 | 2005-08-11 | Reinmüller, Johannes, Dr.med. | Mittel zur Behandlung von entzündlichen Erkrankungen |
-
2006
- 2006-09-25 CA CA2560844A patent/CA2560844C/en not_active Expired - Fee Related
- 2006-09-25 RU RU2006134169/15A patent/RU2342148C2/ru not_active IP Right Cessation
- 2006-09-25 NO NO20064337A patent/NO20064337L/no not_active Application Discontinuation
- 2006-09-26 AR ARP060104194A patent/AR056091A1/es not_active Application Discontinuation
- 2006-09-26 AT AT06020126T patent/ATE552005T1/de active
- 2006-09-26 EP EP06020126A patent/EP1767211B1/de not_active Not-in-force
- 2006-09-26 BR BRMU8603015-9U patent/BRMU8603015U/pt not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| RU2342148C2 (ru) | 2008-12-27 |
| NO20064337L (no) | 2007-03-27 |
| RU2006134169A (ru) | 2008-03-27 |
| CA2560844C (en) | 2011-05-17 |
| CA2560844A1 (en) | 2007-03-26 |
| BRMU8603015U (pt) | 2007-12-11 |
| EP1767211A1 (de) | 2007-03-28 |
| AR056091A1 (es) | 2007-09-19 |
| EP1767211B1 (de) | 2012-04-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUS1400051I1 (hu) | Lurazidont tartalmazó gyógyászati készítmény | |
| ITBO20050123A1 (it) | Formulazioni farmaceutiche gastroresistenti contenenti rifaximina | |
| BRPI0614205A2 (pt) | composto, composição farmacêutica, e, uso de composto | |
| NO20075628L (no) | Farmasøytiske formuleringer | |
| SMP200800041B (it) | Derivati di pirimidinil-aril-urea attivi come-fgf-inibitori | |
| BRPI0618904A2 (pt) | composto, composição farmacêutica, e, uso do composto | |
| EP1748765A4 (de) | Pharmazeutische suspensionszusammensetzung | |
| BRPI0511900A (pt) | composições farmacêuticas | |
| EP1992348A4 (de) | Pharmazeutische kombination | |
| BRPI0719393A2 (pt) | Composição farmacêutica | |
| DK1962873T3 (da) | Farmaceutiske sammensætninger omfattende oxalat-reducerende bakterier | |
| DK1940467T3 (da) | Lægemiddelsammensætning med langvarig frigivelse | |
| ATE493119T1 (de) | Pharmazeutische zusammensetzung | |
| BRPI0720234A2 (pt) | Composição farmacêutica | |
| BRPI0716445A2 (pt) | composiÇço farmacÊutica | |
| BRPI0810399A2 (pt) | Composto, composição farmacêutica que o contém e uso do mesmo | |
| DE502007005902D1 (de) | -methyl-19-nor-20- spirox-4-en-3-one), sowie diese enthaltende pharmazeutische präparate | |
| DK1957073T3 (da) | Lægemiddel | |
| EP2193795A4 (de) | Latanoprosthaltige wässrige pharmazeutische zusammensetzung | |
| DE602008005137D1 (de) | Chinolonverbindung und pharmazeutische zusammensetzung | |
| ATE480227T1 (de) | Pharmazeutische zusammensetzungen mit quetiapinfumarat | |
| EP2156832A4 (de) | Pharmazeutische zusammensetzung | |
| EP1937255A4 (de) | Pharmazeutische zusammensetzung | |
| ITMI20051630A1 (it) | Formulazione farmaceutica sterile iniettabile contenente almeno due principi attivi | |
| ATE552005T1 (de) | Pharmazeutische zusammensetzung hyaluronan als aktive komponente enthaltend |